ArticleBMC health services research2025

Glycated haemoglobin versus fasting plasma glucose for type 2 diabetes point of care screening: a decision model cost-effectiveness analysis.

Francis Xavier Kasujja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.